Knorex Ltd KNRX
- Market cap
- —
- P/E
- —
Follow KNRX
Target Price Range
Analyst price targets
Free account| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | — | — | 1.25 |
Analyst estimates 2026–2028 Powerpack |
Low Price
|
||
| — | — | — | — | — | — | — | — | — | 4.00 |
High Price
|
|||
| — | — | — | — | — | — | — | — | 111 | — |
Employees
|
|||
| — | — | — | — | — | — | — | 0 | 0 | 0 |
Revenue/Emp
|
|||
| — | — | — | — | — | — | — | 9 | 11 | 6 |
Revenue
|
|||
| — | — | — | — | — | — | — | 37.01% | 41.79% | 48.77% |
Gross Margin
|
|||
| — | — | — | — | — | — | — | (8) | (6) | (11) |
EBT
|
|||
| — | — | — | — | — | — | — | (90.90%) | (53.84%) | (189.48%) |
EBT Margin
|
|||
| — | — | — | — | — | — | — | (8) | (6) | (12) |
Net Income
|
|||
| — | — | — | — | — | — | — | 1 | 1 | 1 |
Depreciation
|
|||
| — | — | — | — | — | — | — | 0.36 | 0.40 | 0.21 |
Revenue/Sh
|
|||
| — | — | — | — | — | — | — | (0.33) | (0.22) | (0.41) |
Earnings/Sh
|
|||
| — | — | — | — | — | — | — | (0.23) | (0.20) | (0.37) |
Cash Flow/Sh
|
|||
| — | — | — | — | — | — | — | (0.04) | (0.03) | (0.03) |
Capex/Sh
|
|||
| — | — | — | — | — | — | — | (0.26) | (0.23) | (0.39) |
Free CF/Sh
|
|||
| — | — | — | — | — | — | — | 0.01 | (0.16) | (0.23) |
Book Value/Sh
|
|||
| — | — | — | — | — | — | — | 24 | 27 | 28 |
Shares
|
|||
| — | — | — | — | — | — | — | — | — | — | PE Ratio | |||
| — | — | — | — | — | — | — | — | — | — | PS Ratio | |||
| — | — | — | — | — | — | — | 0.00 | 0.00 | 0.00 |
PB Ratio
|
|||
| — | — | — | — | — | — | — | 0.00 | 0.00 | 0.00 |
EV/Sales
|
|||
| — | — | — | — | — | — | — | 0.00 | 0.00 | 0.00 |
EV/FCF
|
|||
| — | — | — | — | — | — | — | (6) | (5) | (10) |
Op' Cash Flow
|
|||
| — | — | — | — | — | — | — | (1) | (1) | (1) |
Capex
|
|||
| — | — | — | — | — | — | — | (6) | (6) | (11) |
FCF
|
|||
| — | — | — | — | — | — | — | (1) | (6) | (8) |
Working Cap'
|
|||
| — | — | — | — | — | — | — | 1 | 1 | 0 |
Total Debt
|
|||
| — | — | — | — | — | — | — | (1) | 0 | 0 |
Net Debt
|
|||
| — | — | — | — | — | — | — | 0 | (4) | (6) |
Sh' Equity
|
|||
| — | — | — | — | — | — | — | 0.00% | (105.70%) | (186.51%) |
ROA
|
|||
| — | — | — | — | — | — | — | 0.00% | 0.00% | 0.00% |
ROIC
|
|||
| — | — | — | — | — | — | — | 0.00% | 280.18% | 213.14% |
ROE
|
|||
Knorex Ltd (KNRX) key facts
- Knorex Ltd (KNRX) is a Software Application company in the Technology sector, listed on NYSE American.
- Knorex Ltd’s revenue for fiscal 2025 (year ended December 2025) was $6.0 million, down 44.2% from fiscal 2024.
- Knorex Ltd reported a net loss of $11.5 million, or a loss of $0.41 per share, for fiscal 2025.
- Return on equity was 213.1% and debt-to-equity -0.05.
Knorex Ltd (KNRX) Latest News
1 Sep
Knorex Ltd expands its AI-driven advertising suite by launching KAI Assist and integrating XPO MCP Server. New AI tools represent major product launches that can significantly boost Knorex competitive position and growth trajectory.
26 Aug
Knorex Ltd received a NYSE American notice for failing to meet continued listing standards. NYSE delisting risk can severely restrict trading liquidity and damage investor confidence in Knorex Ltd.
29 Apr
Knorex Ltd (KNRX) launches AI-powered XPO Optimizer to target $80 billion market. AI-powered product launch targets $80 billion market, signaling major strategic expansion with high potential to alter competitive positioning.
10 Mar
Knorex Ltd (KNRX) achieved a 47% surge in conversion quality and 45% reduction in cost per acquisition (CPA) following a major upgrade to its KAIROS™ AI models. Major KAIROS AI upgrade delivers quantifiable 47% conversion quality boost and 45% CPA cut, positioning Knorex for enhanced competitive edge and revenue growth.
25 Feb
Knorex Ltd's XPO Platform reduced legal acquisition costs by 29% in a nationwide consumer litigation campaign. 29% cost reduction in nationwide litigation campaign shows platform effectiveness, moderately boosting operational appeal and market sentiment.
23 Feb
Knorex Ltd (KNRX) validates its AI platform's ability to convert national digital awareness campaigns into dealership visits at scale, demonstrating measurable success in driving physical traffic from online efforts. AI platform validation proves real-world efficacy in converting digital campaigns to dealership visits, signaling strong product potential and likely boosting investor sentiment and competitive edge.
19 Feb
Knorex Ltd (KNRX) launches Agentic AI-Ready Ads API, enabling automated cross-channel advertising with AI agents that plan, execute, and optimize campaigns across platforms like Meta, Google, TikTok, and programmatic channels. Agentic AI API launch drives major innovation in cross-channel ad automation, boosting competitive edge and revenue potential.
23 Jan
Knorex Ltd has appointed Michael Sun as its new Chief Financial Officer. Sun brings extensive experience in finance and management, having previously held senior roles in various companies. His appointment is expected to enhance Knorex's financial strategies and operational efficiency as the company continues to grow in the digital marketing sector. The appointment of a new CFO may influence financial performance and operational strategies but is not expected to drastically change the company's trajectory.
31 Dec
Knorex Ltd (KNRX) reported a record advertising spend in Q4, highlighting strong commercial momentum and growth in its business operations. The year-end update indicates a positive trajectory for the company, driven by increased demand for its advertising solutions and strategic initiatives aimed at expanding market presence. Record ad spend and accelerating commercial momentum suggest significant growth potential and improved market positioning.
23 Dec
Knorex Ltd (KNRX) is set to ring the NYSE closing bell on December 29, 2025, marking a significant milestone for the company. This event highlights Knorex's presence in the financial markets and may enhance its visibility among investors and stakeholders. Ringing the NYSE closing bell is a notable event that can positively influence market sentiment and visibility but is unlikely to fundamentally alter the company's trajectory.
18 Dec
Knorex Ltd (KNRX) has launched white-label solutions aimed at enhancing live commerce advertising. These solutions are designed to empower brands and retailers to create customized live shopping experiences, leveraging Knorex's technology to drive engagement and sales. The initiative is expected to cater to the growing demand for interactive online shopping, positioning Knorex as a key player in the evolving e-commerce landscape. The launch of white-label solutions represents a significant strategic move that could enhance Knorex's competitive positioning in the live commerce sector.
9 Dec
Knorex Ltd's AI-powered XPO platform has significantly enhanced operational efficiency and growth for one of Canada's largest dental networks. The platform leverages advanced analytics and machine learning to optimize marketing strategies, resulting in improved patient engagement and increased revenue. This collaboration highlights the effectiveness of Knorex's technology in transforming traditional business models within the healthcare sector. The partnership with a major dental network indicates a significant strategic move that could enhance Knorex's market position and investor sentiment.
15 Oct
Knorex Ltd (KNRX) has announced a strategic partnership with a leading B2B data provider aimed at enhancing its data-driven marketing capabilities. This collaboration is expected to improve Knorex's offerings and strengthen its position in the competitive marketing landscape. The partnership is likely to significantly enhance Knorex's marketing capabilities and competitive positioning.
9 Oct
KNOREX LTD A (KNRX) has announced its recent listing on the NYSE American, as highlighted in a letter from the CEO to shareholders. The letter outlines the company's strategic business outlook, emphasizing growth opportunities and future plans aimed at enhancing shareholder value. The listing is expected to increase visibility and access to capital, positioning KNOREX for potential expansion and innovation in its market sector. The NYSE American listing is a significant strategic move that could enhance capital access and market visibility, impacting future performance.
1 Oct
Knorex Ltd has successfully closed its initial public offering (IPO), raising $12 million. The offering was well-received, indicating strong investor interest in the company's growth potential. The funds raised will be utilized to enhance product development and expand market reach, positioning Knorex for future growth in the competitive landscape. The successful IPO and raised capital are likely to significantly impact Knorex's growth strategy and market positioning.
29 Sep
Knorex Ltd has announced the pricing of its initial public offering (IPO) at $12 million. The company aims to use the proceeds from the IPO to enhance its growth strategies and expand its market presence. This move marks a significant step for Knorex as it transitions into a publicly traded entity, potentially increasing its visibility and access to capital in the competitive landscape. The IPO is a major strategic move that could significantly alter the company's trajectory and investor sentiment.